EW · Healthcare
Edwards Lifesciences Corp
35/100
Smart-money confidence1 of 3 sources positive
Weak — few signals
No standout activity across the feeds we track.
Hedge funds
47
Congress
No data
Insiders
No data
Cross-source blend of hedge-fund breadth, Congress trades, and insider Form 4s. ·
how the score works
Market cap
$52.7B
Industry
Medical Devices
Sector
Healthcare
Exchange
NYSE
About EDWARDS LIFESCIENCES CORP
Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL and EVOQUE brands. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS brand name;…
Who's behind the signal
Every informed buyer we can see on EW, across all three feeds.
Hedge funds · 8
Viking Global Investors
New position
Point72 (Steve Cohen)
Increased +311%
Gotham Asset Mgmt (Greenblatt)
Increased +88%
Bridgewater Associates (Dalio)
Increased +124%
Millennium Management (Englander)
Decreased −70%
AQR Capital Management
Decreased −12%
+2 more in the full breakdown below ↓
Congress · 0
No congressional trades on record.
Insiders
No significant Form 4 insider activity in the window.
Congressional trades · 8 on record
Disclosures from 2020-03-23 to 2021-09-16
The newest disclosure we hold for this stock is 2021-09-16.
That is the end of our data, not necessarily the end of the trading — our
bulk STOCK Act archive stops there and newer filings arrive through a
separate live feed. Treat the absence of recent rows as “not covered”,
not as “no trades”.
| Trade date | Member | Chamber | Action | Amount |
|---|---|---|---|---|
| 2021-09-16 | Katherine M. Clark · D-MA | House | Sold | $1,001 - $15,000 |
| 2021-09-02 | Zoe Lofgren · D-CA | House | Bought | $1,001 - $15,000 |
| 2021-08-09 | Zoe Lofgren · D-CA | House | Bought | $1,001 - $15,000 |
| 2021-07-27 | Katherine M. Clark · D-MA | House | Sold | $1,001 - $15,000 |
| 2021-02-16 | Peter Meijer · R-MI | House | Sold | $1,001 - $15,000 |
| 2021-01-28 | Peter Meijer · R-MI | House | Sold | $1,001 - $15,000 |
| 2020-11-05 | Katherine M. Clark · D-MA | House | Bought | $1,001 - $15,000 |
| 2020-03-23 | Zoe Lofgren · D-CA | House | Sold | $1,001 - $15,000 |
Not a model pick — but on our radar.
EDWARDS LIFESCIENCES CORP isn't in the top-10 model right now, but 8 tracked investors hold it. Everything below is real signal from public filings — treat this as a watch candidate, not a conviction call.
8
Investors
1
New positions
3
Increasing
4
Decreasing
0
Unchanged
Price History
Loading price data...
Return:
High:
Low:
Who's Holding This Stock
Position sizes and recent activity from tracked institutional investors
Trust weight: 1.5×
% of portfolio
0.2%
Position change
NEW
0.2% of Viking Global Investors's portfolio
Trust weight: 1.1×
% of portfolio
0.3%
Position change
+311%
0.3% of Point72's portfolio
Trust weight: 1.1×
% of portfolio
0.1%
Position change
+88%
0.1% of Gotham Asset Mgmt's portfolio
Trust weight: 1.3×
% of portfolio
0.1%
Position change
+124%
0.1% of Bridgewater Associates's portfolio
Trust weight: 1.0×
% of portfolio
0.1%
Position change
−70%
0.1% of Millennium Management's portfolio
Trust weight: 1.0×
% of portfolio
0.1%
Position change
−12%
0.1% of AQR Capital Management's portfolio
Trust weight: 1.4×
% of portfolio
0.0%
Position change
−15%
0.0% of Baillie Gifford & Co's portfolio
Trust weight: 1.0×
% of portfolio
0.0%
Position change
−76%
0.0% of Citadel Advisors's portfolio
Portfolio Allocation
How much of each investor's portfolio is allocated to EDWARDS LIFESCIENCES CORP
⚠ Disclaimer: This page is for informational purposes only. Holdings data from SEC EDGAR 13F filings, delayed up to 135 days. Not a recommendation to buy or sell EDWARDS LIFESCIENCES CORP or any security.
订阅每周更新
我们每周会把巴菲特、达利欧、阿克曼以及另外 47 位传奇投资人正在买入的股票发送给你 — 免费，直接来自他们的 SEC 申报文件。
永久免费 · 无垃圾邮件 · 随时退订